SciSparc Ltd

SPRC

Company Profile

  • Business description

    SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company’s operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

  • Contact

    20 Raul Wallenberg Street
    Tower A, 2nd Floor
    Tel Aviv6971916
    ISR

    T: +972 37175777

    https://www.scisparc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    3

Stocks News & Analysis

stocks

Ask the Analyst: Why are ASX gold miners overvalued despite a near record gold price?

All that glitters is not gold.
stocks

Chart of the Week: Looking past the oil shock to find consumer opportunities

Shoppers are being hit by double whammy of oil and rising rates.
stocks

ASX data center player sells US assets to bolster balance sheet

Asset sale in response to growing investor concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,107.0036.900.41%
CAC 408,202.0897.34-1.17%
DAX 4024,663.61255.08-1.02%
Dow JONES (US)49,623.19287.40-0.58%
FTSE 10010,276.95161.71-1.55%
HKSE26,626.28412.501.57%
NASDAQ25,824.4514.50-0.06%
Nikkei 22562,833.843,320.725.58%
NZX 50 Index13,270.61125.420.95%
S&P 5007,340.2624.86-0.34%
S&P/ASX 2008,878.1032.700.37%
SSE Composite Index4,180.0919.920.48%

Market Movers